Wnt signaling in the vasculature

Experimental Cell Research

Volumn 319, Issue 9, 2013, Pages 1317-1323

  Reis, Marco ^a   Liebner, Stefan ^a  

^a GOETHE UNIVERSITY MEDICAL SCHOOL   (Germany)

Author keywords

Angiogenesis; Beta catenin; Blood brain barrier; Claudin; Norrin; Notch; PDGF B; Pericytes; Wnt

Indexed keywords

BETA CATENIN; NOTCH RECEPTOR; WNT PROTEIN;

ANGIOGENESIS; BLOOD BRAIN BARRIER; CENTRAL NERVOUS SYSTEM; EPITHELIAL MESENCHYMAL TRANSITION; HEART VALVE; HUMAN; MICROVASCULATURE; NONHUMAN; PRIORITY JOURNAL; REVIEW; VASCULARIZATION; WNT SIGNALING PATHWAY;

EID: 84877108215     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2012.12.023     Document Type: Review

References (40)

1. Klaus A., Birchmeier W. Wnt signalling and its impact on development and cancer. Nat. Rev. Cancer 2008, 8:387-398.
2. Liebner S., Plate K.H. Differentiation of the brain vasculature: the answer came blowing by the Wnt. J. Angiogenes Res. 2010, 2:1.
3. Nilsson L.M., Nilsson-Ohman J., Zetterqvist A.V., Gomez M.F. Nuclear factor of activated T-cells transcription factors in the vasculature: the good guys or the bad guys?. Curr. Opin. Lipidol. 2008, 19:483-490.
4. Ju R., Cirone P., Lin S., Griesbach H., Slusarski D.C., Crews C.M. Activation of the planar cell polarity formin DAAM1 leads to inhibition of endothelial cell proliferation, migration, and angiogenesis. Proc. Natl. Acad. Sci. USA 2010, 107:6906-6911.
5. Niehrs C. Function and biological roles of the Dickkopf family of Wnt modulators. Oncogene 2006, 25:7469-7481.
6. Korol O., Gupta R.W., Mercola M. A novel activity of the Dickkopf-1 amino terminal domain promotes axial and heart development independently of canonical Wnt inhibition. Dev. Biol. 2008, 324:131-138.
7. Caneparo L., Huang Y.L., Staudt N., Tada M., Ahrendt R., Kazanskaya O., Niehrs C., Houart C. Dickkopf-1 regulates gastrulation movements by coordinated modulation of Wnt/beta catenin and Wnt/PCP activities, through interaction with the Dally-like homolog Knypek. Genes Dev. 2007, 21:465-480.
8. Mikels A.J., Nusse R. Purified Wnt5a protein activates or inhibits beta-catenin-TCF signaling depending on receptor context. PLoS Biol. 2006, 4:e115.
9. Maye P., Zheng J., Li L., Wu D. Multiple mechanisms for Wnt11-mediated repression of the canonical Wnt signaling pathway. J. Biol. Chem. 2004, 279:24659-24665.
10. Risau W. Mechanisms of angiogenesis. Nature 1997, 386:671-674.
11. Wang H., Charles P.C., Wu Y., Ren R., Pi X., Moser M., Barshishat-Kupper M., Rubin J.S., Perou C., Bautch V., Patterson C. Gene expression profile signatures indicate a role for Wnt signaling in endothelial commitment from embryonic stem cells. Circ. Res. 2006, 98:1331-1339.
12. Wang H., Gilner J.B., Bautch V.L., Wang D.Z., Wainwright B.J., Kirby S.L., Patterson C. Wnt2 coordinates the commitment of mesoderm to hematopoietic, endothelial, and cardiac lineages in embryoid bodies. J. Biol. Chem. 2007, 282:782-791.
13. Aicher A., Kollet O., Heeschen C., Liebner S., Urbich C., Ihling C., Orlandi A., Lapidot T., Zeiher A.M., Dimmeler S. The Wnt antagonist Dickkopf-1 mobilizes vasculogenic progenitor cells via activation of the bone marrow endosteal stem cell niche. Circ. Res. 2008, 103:796-803.
14. Reis M., Czupalla C.J., Ziegler N., Devraj K., Zinke J., Seidel S., Heck R., Thom S., Macas J., Bockamp E., Fruttiger M., Taketo M.M., Dimmeler S., Plate K.H., Liebner S. Endothelial Wnt/beta-catenin signaling inhibits glioma angiogenesis and normalizes tumor blood vessels by inducing PDGF-B expression. J. Exp. Med. 2012, 209:1611-1627.
15. Smadja D.M., d'Audigier C., Weiswald L.B., Badoual C., Dangles-Marie V., Mauge L., Evrard S., Laurendeau I., Lallemand F., Germain S., Grelac F., Dizier B., Vidaud M., Bieche I., Gaussem P. The Wnt antagonist Dickkopf-1 increases endothelial progenitor cell angiogenic potential. Arterioscler. Thromb. Vasc. Biol. 2010, 30:2544-2552.
16. Min J.K., Park H., Choi H.J., Kim Y., Pyun B.J., Agrawal V., Song B.W., Jeon J., Maeng Y.S., Rho S.S., Shim S., Chai J.H., Koo B.K., Hong H.J., Yun C.O., Choi C., Kim Y.M., Hwang K.C., Kwon Y.G. The WNT antagonist Dickkopf2 promotes angiogenesis in rodent and human endothelial cells. J. Clin. Invest. 2011, 121:1882-1893.
17. Yang D.H., Yoon J.Y., Lee S.H., Bryja V., Andersson E.R., Arenas E., Kwon Y.G., Choi K.Y. Wnt5a is required for endothelial differentiation of embryonic stem cells and vascularization via pathways involving both Wnt/beta-catenin and protein kinase Calpha. Circ. Res. 2009, 104:372-379.
18. Brade T., Manner J., Kuhl M. The role of Wnt signalling in cardiac development and tissue remodelling in the mature heart. Cardiovasc Res. 2006, 72:198-209.
19. Phng L.K., Gerhardt H. Angiogenesis: a team effort coordinated by notch. Dev. Cell 2009, 16:196-208.
20. Corada M., Nyqvist D., Orsenigo F., Caprini A., Giampietro C., Taketo M.M., Iruela-Arispe M.L., Adams R.H., Dejana E. The Wnt/beta-catenin pathway modulates vascular remodeling and specification by upregulating Dll4/Notch signaling. Dev. Cell 2010, 18:938-949.
21. Stefater J.A., Lewkowich I., Rao S., Mariggi G., Carpenter A.C., Burr A.R., Fan J., Ajima R., Molkentin J.D., Williams B.O., Wills-Karp M., Pollard J.W., Yamaguchi T., Ferrara N., Gerhardt H., Lang R.A. Regulation of angiogenesis by a non-canonical Wnt-Flt1 pathway in myeloid cells. Nature 2011, 474:511-515.
22. Giles R.H., Lolkema M.P., Snijckers C.M., Belderbos M., van der Groep P., Mans D.A., van Beest M., van Noort M., Goldschmeding R., van Diest P.J., Clevers H., Voest E.E. Interplay between VHL/HIF1alpha and Wnt/beta-catenin pathways during colorectal tumorigenesis. Oncogene 2006, 25:3065-3070.
23. Choi H., Chun Y.S., Kim T.Y., Park J.W. HIF-2alpha enhances beta-catenin/TCF-driven transcription by interacting with beta-catenin. Cancer Res. 2010, 70:10101-10111.
24. Mazzone M., Dettori D., de Oliveira R.Leite, Loges S., Schmidt T., Jonckx B., Tian Y.M., Lanahan A.A., Pollard P., de Almodovar C.Ruiz, De Smet F., Vinckier S., Aragones J., Debackere K., Luttun A., Wyns S., Jordan B., Pisacane A., Gallez B., Lampugnani M.G., Dejana E., Simons M., Ratcliffe P., Maxwell P., Carmeliet P. Heterozygous deficiency of PHD2 restores tumor oxygenation and inhibits metastasis via endothelial normalization. Cell 2009, 136:839-851.
25. Kazanskaya O., Ohkawara B., Heroult M., Wu W., Maltry N., Augustin H.G., Niehrs C. The Wnt signaling regulator R-spondin 3 promotes angioblast and vascular development. Development 2008, 135:3655-3664.
26. Clements W.K., Kim A.D., Ong K.G., Moore J.C., Lawson N.D., Traver D. A somitic Wnt16/Notch pathway specifies haematopoietic stem cells. Nature 2011, 474:220-224.
27. Nikopoulos K., Venselaar H., Collin R.W., Riveiro-Alvarez R., Boonstra F.N., Hooymans J.M., Mukhopadhyay A., Shears D., van Bers M., de Wijs I.J., van Essen A.J., Sijmons R.H., Tilanus M.A., van Nouhuys C.E., Ayuso C., Hoefsloot L.H., Cremers F.P. Overview of the mutation spectrum in familial exudative vitreoretinopathy and Norrie disease with identification of 21 novel variants in FZD4, LRP5, and NDP. Hum. Mutat. 2010, 31:656-666.
28. Junge H.J., Yang S., Burton J.B., Paes K., Shu X., French D.M., Costa M., Rice D.S., Ye W. TSPAN12 regulates retinal vascular development by promoting Norrin but not Wnt-induced FZD4/beta-catenin signaling. Cell 2009, 139:299-311.
29. Ohlmann A., Seitz R., Braunger B., Seitz D., Bosl M.R., Tamm E.R. Norrin promotes vascular regrowth after oxygen-induced retinal vessel loss and suppresses retinopathy in mice. J. Neurosci. 2010, 30:183-193.
30. Zhang J., Fukuhara S., Sako K., Takenouchi T., Kitani H., Kume T., Koh G.Y., Mochizuki N. Angiopoietin-1/Tie2 signal augments basal Notch signal controlling vascular quiescence by inducing delta-like 4 expression through AKT-mediated activation of beta-catenin. J. Biol. Chem. 2011, 286:8055-8066.
31. Maretto S., Cordenonsi M., Dupont S., Braghetta P., Broccoli V., Hassan A.B., Volpin D., Bressan G.M., Piccolo S. Mapping Wnt/beta-catenin signaling during mouse development and in colorectal tumors. Proc. Natl. Acad. Sci. USA 2003, 100:3299-3304.
32. Stenman J.M., Rajagopal J., Carroll T.J., Ishibashi M., McMahon J., McMahon A.P. Canonical Wnt signaling regulates organ-specific assembly and differentiation of CNS vasculature. Science 2008, 322:1247-1250.
33. Liebner S., Corada M., Bangsow T., Babbage J., Taddei A., Czupalla C.J., Reis M., Felici A., Wolburg H., Fruttiger M., Taketo M.M., von Melchner H., Plate K.H., Gerhardt H., Dejana E. Wnt/beta-catenin signaling controls development of the blood-brain barrier. J. Cell Biol. 2008, 183:409-417.
34. Daneman R., Agalliu D., Zhou L., Kuhnert F., Kuo C.J., Barres B.A. Wnt/beta-catenin signaling is required for CNS, but not non-CNS, angiogenesis. Proc. Natl. Acad. Sci. USA 2009, 106:641-646.
35. Moro E., Ozhan-Kizil G., Mongera A., Beis D., Wierzbicki C., Young R.M., Bournele D., Domenichini A., Valdivia L.E., Lum L., Chen C., Amatruda J.F., Tiso N., Weidinger G., Argenton F. In vivo Wnt signaling tracing through a transgenic biosensor fish reveals novel activity domains. Dev. Biol. 2012, 366:327-340.
36. Wang Y., Rattner A., Zhou Y., Williams J., Smallwood P.M., Nathans J. Norrin/Frizzled4 signaling in retinal vascular development and blood brain barrier plasticity. Cell 2012, 151:1332-1344.
37. Daneman R., Zhou L., Kebede A.A., Barres B.A. Pericytes are required for blood-brain barrier integrity during embryogenesis. Nature 2010, 468:562-566.
38. Armulik A., Genove G., Mae M., Nisancioglu M.H., Wallgard E., Niaudet C., He L., Norlin J., Lindblom P., Strittmatter K., Johansson B.R., Betsholtz C. Pericytes regulate the blood-brain barrier. Nature 2010, 468:557-561.
39. del Toro R., Prahst C., Mathivet T., Siegfried G., Kaminker J.S., Larrivee B., Breant C., Duarte A., Takakura N., Fukamizu A., Penninger J., Eichmann A. Identification and functional analysis of endothelial tip cell-enriched genes. Blood 2010, 116:4025-4033.
40. Zhang X., Gaspard J.P., Chung D.C. Regulation of vascular endothelial growth factor by the Wnt and K-ras pathways in colonic neoplasia. Cancer Res. 2001, 61:6050-6054.